[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=92c01a8f2c68a5c7b9dc2da45c54e8134ad87be1b2f5485f5d0419790bf869aa",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746117360,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
      "id": 134190902,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=92c01a8f2c68a5c7b9dc2da45c54e8134ad87be1b2f5485f5d0419790bf869aa"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Growth Portfolios Q1 2025 Commentary",
    "summary": "The Portfolios' resilience in a down quarter for growth stocks was supported by our balanced, pyramid of growth approach to portfolio construction.",
    "url": "https://finnhub.io/api/news?id=832fb4652ad364051f275d5cbfa0f7031d78e08054517bbd7d77c179d9b75ddc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746092100,
      "headline": "ClearBridge Growth Portfolios Q1 2025 Commentary",
      "id": 134171952,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359132436/image_1359132436.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The Portfolios' resilience in a down quarter for growth stocks was supported by our balanced, pyramid of growth approach to portfolio construction.",
      "url": "https://finnhub.io/api/news?id=832fb4652ad364051f275d5cbfa0f7031d78e08054517bbd7d77c179d9b75ddc"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Growth ESG Portfolios Q1 2025 Commentary",
    "summary": "The Portfolios' resilience in a down quarter for growth stocks was supported by our balanced, pyramid of growth approach to portfolio construction.",
    "url": "https://finnhub.io/api/news?id=d5164fca70986f5a84488de4e3e6088daded765ee8d27a5a08efeac607525d5c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746091800,
      "headline": "ClearBridge Growth ESG Portfolios Q1 2025 Commentary",
      "id": 134171956,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2129394085/image_2129394085.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The Portfolios' resilience in a down quarter for growth stocks was supported by our balanced, pyramid of growth approach to portfolio construction.",
      "url": "https://finnhub.io/api/news?id=d5164fca70986f5a84488de4e3e6088daded765ee8d27a5a08efeac607525d5c"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge All Cap Growth Portfolios Q1 2025 Commentary",
    "summary": "Tariffs were just one of the headwinds impacting the Magnificent Seven 5 as all except Meta Platforms underperformed the index.",
    "url": "https://finnhub.io/api/news?id=3ead6ee28d30967ff8a9985c1d555e9d60b44befb83ea3476115bc3418efaf73",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746090900,
      "headline": "ClearBridge All Cap Growth Portfolios Q1 2025 Commentary",
      "id": 134171890,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182036952/image_2182036952.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Tariffs were just one of the headwinds impacting the Magnificent Seven 5 as all except Meta Platforms underperformed the index.",
      "url": "https://finnhub.io/api/news?id=3ead6ee28d30967ff8a9985c1d555e9d60b44befb83ea3476115bc3418efaf73"
    }
  }
]